Replies to post #85678 on Savvy Trades and Investments

[RNsidersbuying]

ODT 3.35 - with approx. $3.50 BV at 12/31/21 (mostly cash), I'm not seeing any dissolution in my crystal ball. From my experience, they'll likely announce a re-structuring to conserve cash while seeking new ventures ie: similar to another SPAC - with one huge advantage in the potential $366M "Accumulated Deficit" writeoff...

Accumulated deficit (366,427)

https://secfilings.nasdaq.com/filingFrameset.asp?FilingID=14733684&RcvdDate=2/23/2021&CoName=ODONATE%20THERAPEUTICS,%20INC.&FormType=10-K&View=html

Of note: a few years ago these biobusts would frequently dip down below cash but not so in this crazybonkers market...guessing they will again eventually...